Beiersdorf


Fuelling CARE

17/02/21 -"The higher investments under the umbrella of the already expensive CARE programme have to seen and valued against the back of the current CEO’s predecessor and his targets. This meaningful ..."

Pages
53
Language
English
Published on
17/02/21
You may also be interested by these reports :
08/05/24
The management appeared confident regarding the business performance in 2024. Furthermore, it disclosed some additional details on the phasing of the ...

03/05/24
Essity reported a decent set of Q1 24 figures, just meeting the top-line consensus but delivering a handy beat on the bottom line. More importantly, ...

02/05/24
We have integrated the figures in the annual report. The higher 2023 profitability came from the better performance of the newly-created Consumer ...

01/05/24
Haleon’s Q1 24 operating profit exceeded the street’s expectations, despite in line sales. The top-line growth was supported by a healthy performance ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO